Inhibition of PITX1 leads to activation of the RAS pathway and promotes tumorigenesis, whereas restoration of PITX1 in colon cancer cells suppresses tumorigenesis (Chapter 3 provides a detailed explanation of this phenomenon). Here, PITX1 is linked to malignant colon neoplasm.